Chargement en cours...

Predictors of effectiveness of glucagon-like peptide-1 receptor agonist therapy in patients with type 2 diabetes and obesity

Background: Type 2 diabetes mellitus (DM2), which mainly develops from visceral obesity, is a socially significant disease. Reduction of losses from DM2 is a priority in modern medicine development. Glucagon-like peptide-1 receptor agonists (aGLP-1) present one of few groups of antidiabetic drugs th...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Ekaterina V. Tikhonenko, Alina Y. Babenko, Evgeny V. Shlyakhto
Format: Artigo
Langue:Inglês
Publié: Endocrinology Research Centre 2018-12-01
Collection:Ожирение и метаболизм
Sujets:
Accès en ligne:https://www.omet-endojournals.ru/jour/article/view/9584
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!